4.7 Article

The efficacy of alendronate for the treatment of thalassemia-associated osteoporosis: a randomized controlled trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience

Irene Gagliardi et al.

Summary: This study retrospectively evaluated the efficacy and safety of teriparatide (TP) in the treatment of TM-associated osteoporosis in real-life clinical practice. The results showed that TP significantly improved bone mineral density, especially at the lumbar spine, and prevented fractures. However, some patients experienced side effects such as muscle and bone pain.

CALCIFIED TISSUE INTERNATIONAL (2022)

Article Hematology

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia

Dimitrios Farmakis et al.

Summary: Beta-thalassemia, especially its transfusion-dependent form (TDT), requires lifelong care and follow-up, presenting challenges in its management. Thalassaemia International Federation (TIF) strives to promote equal access to quality care for all thalassemia patients worldwide. In 2021, TIF published the fourth edition of guidelines for TDT management, providing detailed information and recommendations for healthcare professionals.

HEMASPHERE (2022)

Review Endocrinology & Metabolism

Impact of iron overload on bone remodeling in thalassemia

Pokpong Piriyakhuntorn et al.

ARCHIVES OF OSTEOPOROSIS (2020)

Article Medicine, Research & Experimental

Bone Metabolism Markers in Thalassemia Major-Induced Osteoporosis: Results from a Cross-Sectional Observational Study

Athanasios N. Tsartsalis et al.

CURRENT MOLECULAR MEDICINE (2019)

Article Endocrinology & Metabolism

Comparative effectiveness of alendronate and zoledronic acid on bone mass improvement in transfusion-dependent thalassemia patients

Omid Reza Zekavat et al.

JOURNAL OF BONE AND MINERAL METABOLISM (2019)

Review Endocrinology & Metabolism

Pathogenesis of Thalassemia Major-associated Osteoporosis: A Review with Insights from Clinical Experience

Agostino Gaudio et al.

JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2019)

Review Geriatrics & Gerontology

Turner syndrome and osteoporosis

Areti Augoulea et al.

MATURITAS (2019)

Review Endocrinology & Metabolism

The role of biphosphonates in the management of thalassemia-induced osteoporosis: a systematic review and meta-analysis

Athanasios N. Tsartsalis et al.

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (2018)

Article Endocrinology & Metabolism

Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis

Nunziata Morabito et al.

JOURNAL OF BONE AND MINERAL METABOLISM (2016)

Article Hematology

Management of beta-thalassemia-associated osteoporosis

Andrea Giusti et al.

COOLEY'S ANEMIA (2016)

Article Hematology

Thalassemic osteopathy: A new marker of bone deposition

M. Baldini et al.

BLOOD CELLS MOLECULES AND DISEASES (2014)

Article Endocrinology & Metabolism

Treatment failure in osteoporosis

A. Diez-Perez et al.

OSTEOPOROSIS INTERNATIONAL (2012)

Article Endocrinology & Metabolism

Bone Mass in Subjects with Klinefelter Syndrome: Role of Testosterone Levels and Androgen Receptor Gene CAG Polymorphism

Alberto Ferlin et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Article Endocrinology & Metabolism

The lively cytokines network in β-Thalassernia Major-related osteoporosis

Nunziata Morabito et al.

Article Endocrinology & Metabolism

Bisphosphonates in the treatment of thalassemia-induced osteoporosis

N Morabito et al.

OSTEOPOROSIS INTERNATIONAL (2002)